Copyright Reports & Markets. All rights reserved.

Global Gonadotropin-releasing Hormone Antagonists Market Research Report 2021

Request for Sample of this report
Buy now

1 Gonadotropin-releasing Hormone Antagonists Market Overview

  • 1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Antagonists
  • 1.2 Gonadotropin-releasing Hormone Antagonists Segment by Type
    • 1.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Peptides
    • 1.2.3 Small Molecules
  • 1.3 Gonadotropin-releasing Hormone Antagonists Segment by Application
    • 1.3.1 Global Gonadotropin-releasing Hormone Antagonists Sales Comparison by Application: (2021-2027)
    • 1.3.2 Prostate Cancer
    • 1.3.3 Endometriosis
    • 1.3.4 Uterine Fibroids
    • 1.3.5 Female Infertility
    • 1.3.6 Others
  • 1.4 Global Gonadotropin-releasing Hormone Antagonists Market Size Estimates and Forecasts
    • 1.4.1 Global Gonadotropin-releasing Hormone Antagonists Revenue 2016-2027
    • 1.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales 2016-2027
    • 1.4.3 Gonadotropin-releasing Hormone Antagonists Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gonadotropin-releasing Hormone Antagonists Market Competition by Manufacturers

  • 2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Gonadotropin-releasing Hormone Antagonists Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Gonadotropin-releasing Hormone Antagonists Manufacturing Sites, Area Served, Product Type
  • 2.5 Gonadotropin-releasing Hormone Antagonists Market Competitive Situation and Trends
    • 2.5.1 Gonadotropin-releasing Hormone Antagonists Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue
    • 2.5.3 Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario by Region

  • 3.1 Global Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Gonadotropin-releasing Hormone Antagonists Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
    • 3.3.1 North America Gonadotropin-releasing Hormone Antagonists Sales by Country
    • 3.3.2 North America Gonadotropin-releasing Hormone Antagonists Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
    • 3.4.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country
    • 3.4.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region
    • 3.5.2 Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
    • 3.6.1 Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country
    • 3.6.2 Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country
    • 3.7.2 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Gonadotropin-releasing Hormone Antagonists Historic Market Analysis by Type

  • 4.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
  • 4.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2016-2021)
  • 4.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2016-2021)

5 Global Gonadotropin-releasing Hormone Antagonists Historic Market Analysis by Application

  • 5.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
  • 5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2016-2021)
  • 5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 AbbVie
    • 6.1.1 AbbVie Corporation Information
    • 6.1.2 AbbVie Description and Business Overview
    • 6.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.1.5 AbbVie Recent Developments/Updates
  • 6.2 Takeda
    • 6.2.1 Takeda Corporation Information
    • 6.2.2 Takeda Description and Business Overview
    • 6.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.2.5 Takeda Recent Developments/Updates
  • 6.3 Astellas
    • 6.3.1 Astellas Corporation Information
    • 6.3.2 Astellas Description and Business Overview
    • 6.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.3.5 Astellas Recent Developments/Updates
  • 6.4 Kissei
    • 6.4.1 Kissei Corporation Information
    • 6.4.2 Kissei Description and Business Overview
    • 6.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.4.5 Kissei Recent Developments/Updates
  • 6.5 Veru Inc
    • 6.5.1 Veru Inc Corporation Information
    • 6.5.2 Veru Inc Description and Business Overview
    • 6.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.5.5 Veru Inc Recent Developments/Updates
  • 6.6 Myovant Sciences
    • 6.6.1 Myovant Sciences Corporation Information
    • 6.6.2 Myovant Sciences Description and Business Overview
    • 6.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.6.5 Myovant Sciences Recent Developments/Updates
  • 6.7 AstraZeneca
    • 6.6.1 AstraZeneca Corporation Information
    • 6.6.2 AstraZeneca Description and Business Overview
    • 6.6.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.7.5 AstraZeneca Recent Developments/Updates
  • 6.8 Ferring Pharmaceuticals
    • 6.8.1 Ferring Pharmaceuticals Corporation Information
    • 6.8.2 Ferring Pharmaceuticals Description and Business Overview
    • 6.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.8.5 Ferring Pharmaceuticals Recent Developments/Updates
  • 6.9 Jiangsu Hengrui Medicine Co
    • 6.9.1 Jiangsu Hengrui Medicine Co Corporation Information
    • 6.9.2 Jiangsu Hengrui Medicine Co Description and Business Overview
    • 6.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
    • 6.9.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates

7 Gonadotropin-releasing Hormone Antagonists Manufacturing Cost Analysis

  • 7.1 Gonadotropin-releasing Hormone Antagonists Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Antagonists
  • 7.4 Gonadotropin-releasing Hormone Antagonists Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gonadotropin-releasing Hormone Antagonists Distributors List
  • 8.3 Gonadotropin-releasing Hormone Antagonists Customers

9 Gonadotropin-releasing Hormone Antagonists Market Dynamics

  • 9.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
  • 9.2 Gonadotropin-releasing Hormone Antagonists Growth Drivers
  • 9.3 Gonadotropin-releasing Hormone Antagonists Market Challenges
  • 9.4 Gonadotropin-releasing Hormone Antagonists Market Restraints

10 Global Market Forecast

  • 10.1 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Type (2022-2027)
  • 10.2 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Application (2022-2027)
  • 10.3 Gonadotropin-releasing Hormone Antagonists Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Antagonists by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Antagonists by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Peptides
    Small Molecules

    Segment by Application
    Prostate Cancer
    Endometriosis
    Uterine Fibroids
    Female Infertility
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    AbbVie
    Takeda
    Astellas
    Kissei
    Veru Inc
    Myovant Sciences
    AstraZeneca
    Ferring Pharmaceuticals
    Jiangsu Hengrui Medicine Co

    Buy now